Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Boehringer Ingelheim identifies new NR2B receptor negative allosteric modulators

May 11, 2020

Inhibition of P2X7 receptors improves synaptic and behavioral deficits in a Rett syndrome model

May 11, 2020

Winter depression-like behavior is regulated by seasonal changes in the NRF2 pathway

May 11, 2020

Ovid reports topline phase II data with OV-101 in fragile X syndrome

May 8, 2020

Sage Therapeutics discloses GABA-A receptor modulators

May 8, 2020

FDA approves Elyxyb for acute treatment of migraine with or without aura

May 7, 2020

New mouse model of mild spinal muscular atrophy

May 7, 2020

Suven Life Sciences describes new muscarinic M1 receptor PAMs

May 7, 2020

Carbohydrate metabolism implicated in neuropathy

May 7, 2020

Sphingolipids accumulate in neurodegeneration

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...